Sabine Blum

2.1k total citations
59 papers, 976 citations indexed

About

Sabine Blum is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Sabine Blum has authored 59 papers receiving a total of 976 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Hematology, 15 papers in Oncology and 14 papers in Genetics. Recurrent topics in Sabine Blum's work include Acute Myeloid Leukemia Research (20 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (12 papers) and Hematological disorders and diagnostics (9 papers). Sabine Blum is often cited by papers focused on Acute Myeloid Leukemia Research (20 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (12 papers) and Hematological disorders and diagnostics (9 papers). Sabine Blum collaborates with scholars based in Switzerland, Germany and United States. Sabine Blum's co-authors include Mathias Lamparter, Antonis K. Hatzopoulos, Peter Vajkoczy, Reinhard Mailhammer, Ralph Erber, Britta Engelhardt, Dietmar Vestweber, Georg Breier, Werner Risau and Olaia Naveiras and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Sabine Blum

54 papers receiving 963 citations

Peers

Sabine Blum

HEMAT

GENET

ONCOL

Mohammad Shahjahani Iran

Seiji Kojima Japan

Maria‐Theresa Krauth Austria

Shunya Arai Japan

Youshan Zhao China

Kazuma Ikeda Japan

Yao-Qi Huang United States

Elspeth Payne United Kingdom

F Viguié France

Melvin M. Denis United States

Mohammad Shahjahani Iran

Sabine Blum

580 ×1.4

463 ×1.6

HEMAT

350 ×1.5

GENET

247 ×1.2

ONCOL

267 ×1.9

Citations per year, relative to Sabine Blum Sabine Blum (= 1×) peers Mohammad Shahjahani

Countries citing papers authored by Sabine Blum

Since Specialization

Citations

This map shows the geographic impact of Sabine Blum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sabine Blum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sabine Blum more than expected).

Fields of papers citing papers by Sabine Blum

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sabine Blum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sabine Blum. The network helps show where Sabine Blum may publish in the future.

Co-authorship network of co-authors of Sabine Blum

This figure shows the co-authorship network connecting the top 25 collaborators of Sabine Blum. A scholar is included among the top collaborators of Sabine Blum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sabine Blum. Sabine Blum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wolff, Louis, et al.. (2024). Understanding Myelodysplasia and Inflammation Through the Lense of VEXAS Syndrome: A Review. Cells. 13(22). 1890–1890.

Blum, Sabine, et al.. (2024). Differentiation syndrome in acute promyelocytic leukemia: A leopard cannot change its spots. International Journal of Laboratory Hematology. 46(6). 983–984.

Liu, Wangjie, Jessica Sordet‐Dessimoz, Olivier Spertini, et al.. (2024). Single-Cell Transcriptomic and Spatial Characterization of Multipotent Stromal Cells in Homeostatic,Remodeled, and In Vitro Expanded Human Bone Marrow. Blood. 144(Supplement 1). 4061–4061. 1 indexed citations

Papadopoulou, Vasiliki, et al.. (2023). Single-center, observational study of AML/MDS-EB with IDH1/2 mutations: genetic profile, immunophenotypes, mutational kinetics and outcomes. Hematology. 28(1). 2180704–2180704. 3 indexed citations

Burri, Olivier, Stéphane Cherix, Carmen Bárcena, et al.. (2023). MarrowQuant 2.0: A Digital Pathology Workflow Assisting Bone Marrow Evaluation in Experimental and Clinical Hematology. Modern Pathology. 36(4). 100088–100088. 9 indexed citations

Silzle, Tobias, Sabine Blum, Kathrin Nachtkamp, et al.. (2023). The Absolute Monocyte Count at Diagnosis Affects Prognosis in Myelodysplastic Syndromes Independently of the IPSS-R Risk Score. Cancers. 15(14). 3572–3572. 2 indexed citations

Opota, Onya, et al.. (2023). Oedème palpébral 24 heures après le premier vaccin contre le COVID-19. Forum Médical Suisse ‒ Swiss Medical Forum. 1 indexed citations

Papadopoulou, Vasiliki, et al.. (2023). Description of an Institutional Cohort of Myeloid Neoplasms Carrying ETV6-Locus Deletions or ETV6 Rearrangements. Acta Haematologica. 146(5). 401–407.

Τσιλιμιδός, Γεράσιμος, et al.. (2023). Refined cytogenetic IPSS‐R evaluation by the use of SNP array in a cohort of 290 MDS patients. Genes Chromosomes and Cancer. 62(12). 721–731. 2 indexed citations

10.

Robinson, Matthew R., Marion Patxot, Miloš Stojanov, Sabine Blum, & David Baud. (2021). Postpartum hemorrhage risk is driven by changes in blood composition through pregnancy. Scientific Reports. 11(1). 19238–19238. 4 indexed citations

11.

Martins, Filipe, et al.. (2020). Characterization of myelodysplastic syndromes progressing to acute lymphoblastic leukemia. Annals of Hematology. 100(1). 63–78. 3 indexed citations

12.

Schuler, Esther, Sabine Blum, Thomas Schroeder, et al.. (2018). Long-term outcome of high risk patients with myelodysplastic syndromes or secondary acute myeloid leukemia receiving intensive chemotherapy. Annals of Hematology. 97(12). 2325–2332. 12 indexed citations

13.

Cairoli, Anne, Olaia Naveiras, Laurence de Leval, et al.. (2017). Response to MEK inhibition with trametinib and tyrosine kinase inhibition with imatinib in multifocal histiocytic sarcoma. Haematologica. 103(1). e39–e41. 25 indexed citations

14.

Mendell, Jeanne, Daniel J. Freeman, Wenqin Feng, et al.. (2015). Clinical Translation and Validation of a Predictive Biomarker for Patritumab, an Anti-human Epidermal Growth Factor Receptor 3 (HER3) Monoclonal Antibody, in Patients With Advanced Non-small Cell Lung Cancer. EBioMedicine. 2(3). 264–271. 30 indexed citations

15.

Wunder, Dorothea, et al.. (2015). Ten Year Single-Center Experience in Fertility Preservation of 459 Patients Suffering from Acute Leukaemia. Blood. 126(23). 3751–3751. 1 indexed citations

16.

Passweg, Jakob, Thomas Pabst, Sabine Blum, et al.. (2013). Azacytidine for acute myeloid leukemia in elderly or frail patients: a phase II trial (SAKK 30/07). Leukemia & lymphoma. 55(1). 87–91. 22 indexed citations

17.

Neukirchen, Judith, Michael Lauseker, Sabine Blum, et al.. (2013). Validation of the revised International Prognostic Scoring System (IPSS-R) in patients with myelodysplastic syndrome: A multicenter study. Leukemia Research. 38(1). 57–64. 46 indexed citations

18.

Wei, Jiwu, Sabine Blum, Marcus M. Unger, et al.. (2004). Embryonic endothelial progenitor cells armed with a suicide gene target hypoxic lung metastases after intravenous delivery. Cancer Cell. 5(5). 477–488. 87 indexed citations

19.

Blum, Sabine, Ingrid Groth, Jürgen Rohr, & Hans‐Peter Fiedler. (1996). Biosynthetic capacities of actinomycetes. 5. Dioxolides, novel secondary metabolites from Streptomyces tendae. Journal of Basic Microbiology. 36(1). 19–25. 8 indexed citations

20.

Blum, Sabine, Hans‐Peter Fiedler, Ingrid Groth, et al.. (1995). Biosynthetic Capacities of Actinomycetes. 4. Echinoserine, a New Member of the Quinoxaline Group, Produced by Streptomyces tendae.. The Journal of Antibiotics. 48(7). 619–625. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact